Target intelligence / Profile preview

1,3-beta-glucan synthase (Fks1 (for *Saccharomyces cerevisiae* and many fungi))

Target
Fks1 (for *Saccharomyces cerevisiae* and many fungi)
Molecular classification
Enzyme, Glycosyltransferase (CAZy family GT48), Integral membrane protein
01

Overview

1,3-beta-glucan synthase is an integral membrane glycosyltransferase complex responsible for catalyzing the formation of 1,3-beta-glucan, a major structural polysaccharide of most fungal cell walls. In *Saccharomyces cerevisiae* and most pathogenic fungi, the principal component is Fks1, a large, multi-pass transmembrane protein with a central glycosyltransferase (GT-A) domain (CAZy family GT48) and a transmembrane channel that exports synthesized glucan. The enzyme uses UDP-glucose as substrate to build β-1,3-glycosidic linkages, contributing to cell wall rigidity and osmotic stability. Its activity is regulated by Rho1 GTPase, and drugs targeting this enzyme (like echinocandins and ibrexafungerp) interrupt glucan synthesis, leading to cell wall defects and cell death, making it a validated and clinically important antifungal drug target.

Other names
β-1,3-glucan synthasebeta-1,3-glucan synthaseGSFks1Gls1Gls2Gls3GLS (family)1,3-β-glucan synthase
02

Mechanism of action

Inhibition of β-1,3-glucan synthesis, leading to weakened fungal cell wall and cell lysis

03

Biological functions

Synthesis of β-1,3-glucanFungal cell wall biosynthesisCell wall assemblyFungal growth and morphology
04

Disease associations

Infection (fungal pathogens)Antifungal drug target
05

Safety considerations

Echinocandins can have hepatic toxicity and are generally not active against all fungi (resistance can occur with FKS1 mutations)Off-target effects and challenges with drug bioavailability and penetration in certain tissues
06

Interacting drugs

Echinocandins (e.g., caspofungin, micafungin, anidulafungin)

1 more in the full profile.

07

Biomarkers

1,3-β-D-glucan (serologic marker for fungal infection, but not a direct marker of synthase expression/activity)

Beyond the preview

Go deeper on 1,3-beta-glucan synthase (Fks1 (for *Saccharomyces cerevisiae* and many fungi)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1,3-beta-glucan synthase (Fks1 (for *Saccharomyces cerevisiae* and many fungi)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call